Contraindications: Mechanical obstruction: should not be given to patients having any form of mechanical obstruction in the GI tract or bladder Compromised GI or Bladder Wall Integrity : should not be given to patients where the integrity of the gastrointestinal or bladder wall is in question Hypersensitivity to bethanechol chloride tablets, Hyperthyroidism Peptic ulcer Latent or active bronchial asthma, Pronounced bradycardia or hypotension Vasomotor instability Coronary artery disease Epilepsy Parkinsonism Side Effects: Early signs of overdosage are abdominal discomfort, blurred vision, salivation, flushing of the skin (hot feeling), sweating, nausea and vomiting ( SLUDE-like symptoms ) 2) , bronchoconstriction, increased stomach acid secretion, hypotension
Burping or sulfur-tasting reflux , which usually fades within 2 weeks
Novel therapy targeting for c-Met and EPCAM C-Met and novel therapy Anti-c-Met agents can be classified into four types: selective c-Met tyrosine kinase inhibitors (TKIs), non-selective c-Met inhibitors, monoclonal antibodies against HGF/c-Met, and microRNAs (miRNAs)
As we continue to explore the potential of peptides like BPC 157, it's clear that rigorous research and careful application are key to unlocking their full potential
Very quick, easy, and simple process